MiMedx Group (MDXG) Tops Q4 EPS by 1c

MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $39.6 million versus the consensus estimate of $38.15 million. MiMedx Group reaffirmed FY2015 guidance.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Equinox Gold Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders to Approve Business Combination with Orla Mining